Premium
Single‐agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study
Author(s) -
Cejalvo María J.,
Legarda Mario,
Abella Eugenia,
Cabezudo Elena,
Encinas Cristina,
GarcíaFeria Ana,
Gironella Mercedes,
Iñigo Belén,
Martín Jesús,
Ribas Paz,
Ruíz Mª Ángeles,
González Yolanda,
Vicuña Isabel,
Ramírez Ángel,
Fernández Pascual,
Rubia Javier
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16286
Subject(s) - daratumumab , hematology , medicine , multiple myeloma , oncology , dialysis , intensive care medicine , lenalidomide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom